Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes. 2019 Mar 26;:1-20. [Epub ahead of print] PubMed PMID: 30913966
Alula KM, Delgado-Deida Y, Jackson DN, Venuprasad K, Theiss AL. Nuclear partitioning of Prohibitin 1 inhibits Wnt/ß-catenin-dependent intestinal tumorigenesis. Oncogene. 2020 Nov 3. [Epub ahead of print] PubMed PMID: 33144683
Delgado-Deida Y, Alula KM, Theiss AL. The influence of mitochondrial-directed regulation of Wnt signaling on tumorigenesis. Gastroenterol Rep (Oxf). 2020 Jun;8(3):215-223. PubMed PMID: 32665853
Jackson DN, Alula KM, Delgado-Deida Y, Tabti R, Turner K, Wang X, Venuprasad K, Souza RF, Désaubry L, Theiss AL. The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/ß-Catenin Signaling. Cancer Res. 2020 Sep 1;80(17):3519-3529. PubMed PMID: 32665357
Mukherjee S, Kumar R, Tsakem Lenou E, Basrur V, Kontoyiannis DL, Ioakeimidis F, Mosialos G, Theiss AL, Flavell RA, Venuprasad K. Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation. Nat Immunol. 2020 Jun;21(6):626-635. PubMed PMID: 32424362
Kathania M, Tsakem EL, Theiss AL, Venuprasad K. Gut Microbiota Contributes to Spontaneous Colitis in E3 Ligase Itch-Deficient Mice. J Immunol. 2020 Apr 15;204(8):2277-2284. PubMed PMID: 32169841
Jackson DN, Panopoulos M, Neumann WL, Turner K, Cantarel BL, Thompson-Snipes L, Dassopoulos T, Feagins LA, Souza RF, Mills JC, Blumberg RS, Venuprasad K, Thompson WE, Theiss AL. Mitochondrial dysfunction during loss of prohibitin 1 triggers Paneth cell defects and ileitis. Gut. 2020 Nov;69(11):1928-1938. PubMed PMID: 32111635
Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes. 2020 May 3;11(3):285-304. PubMed PMID: 30913966
Kumar R, Theiss AL, Venuprasad K. ROR?t protein modifications and IL-17-mediated inflammation. Trends Immunol. 2021 Nov;42(11):1037-1050. PubMed PMID: 34635393
Ho GT, Theiss AL. Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention. Annu Rev Physiol. 2021 Oct 6. [Epub ahead of print] PubMed PMID: 34614372
Alula KM, Jackson DN, Smith AD, Kim DS, Turner K, Odstrcil E, Kaipparettu BA, Dassopoulos T, Venuprasad K, Feagins LA, Theiss AL. Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease. Cells. 2021 May 29;10(6). PubMed PMID: 34072441
Theiss AL. Autophagy and Cancer: Current Biology & Drug Development In Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications, Physiology in Health and Disease Series. New York, NY: Springer Nature.
Venuprasad K, Theiss AL. NLRP6 in host defense and intestinal inflammation. Cell Rep. 2021 Apr 27;35(4):109043. PubMed PMID: 33910012
Kumar R, Singh AK, Starokadomskyy P, Luo W, Theiss AL, Burstein E, Venuprasad K. Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis. J Immunol. 2021 Mar 1;206(5):936-940. PubMed PMID: 33504619
Kumar J, Kumar R, Kumar Singh A, Tsakem EL, Kathania M, Riese MJ, Theiss AL, Davila ML, Venuprasad K. Deletion of Cbl-b inhibits CD8( ) T-cell exhaustion and promotes CAR T-cell function. J Immunother Cancer. 2021 Jan;9(1). PubMed PMID: 33462140
Alula KM, Delgado-Deida Y, Jackson DN, Venuprasad K, Theiss AL. Nuclear partitioning of Prohibitin 1 inhibits Wnt/ß-catenin-dependent intestinal tumorigenesis. Oncogene. 2021 Jan;40(2):369-383. PubMed PMID: 33144683
Kathania M, Kumar R, Lenou ET, Basrur V, Theiss AL, Chernoff J, Venuprasad K. Pak2-mediated phosphorylation promotes ROR?t ubiquitination and inhibits colonic inflammation. Cell Rep. 2022 Sep 13;40(11):111345. PubMed PMID: 36103814
Ho GT, Theiss AL. Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention. Annu Rev Physiol. 2022 Feb 10;84:435-459. PubMed PMID: 34614372
Mukherjee S, Kumar R, Theiss AL, Venuprasad K. Advances in the analysis of protein ubiquitination, In Advances in Protein Molecular and Structural Biology Methods. Elsevier. 2022; 635-640.
Tsakem E, Mukherjee S, Theiss AL, Venuprasad K. “Cellular signaling, molecular activation, and regulation of the NLRP6 inflammasome” In Inflammasome Biology. Elsevier. 2023; in press.
Adams JC, Price OJ, Rogers N, Rounds S, Taruno A, Theiss AL, Uchida S, Wright DC. Physiological Reports celebrates its first 10?years. Physiol Rep. 2023 Dec;11(23):e15874. PubMed PMID: 38016666
Alula KM, Dowdell AS, LeBere B, Lee JS, Levens CL, Kuhn KA, Kaipparettu BA, Thompson WE, Blumberg RS, Colgan SP, Theiss AL. Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice. Microbiome. 2023 Nov 17;11(1):256. PubMed PMID: 37978573
Alula KM, Theiss AL. Autophagy in Crohn's Disease: Converging on Dysfunctional Innate Immunity. Cells. 2023 Jul 4;12(13). PubMed PMID: 37443813
Theiss AL. Ptpn2: A Critical Regulator of Paneth Cell Homeostasis. Cell Mol Gastroenterol Hepatol. 2023;16(1):163-164. PubMed PMID: 37098410
Alula KM, Delgado-Deida Y, Callahan R, Till A, Underwood L, Thompson WE, Souza RF, Dassopoulos T, Onyiah J, Venuprasad K, Theiss AL. Inner mitochondrial membrane protein Prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy. Sci Rep. 2023 Jan 2;13(1):18. PubMed PMID: 36593241